These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17916204)

  • 1. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.
    Krishnan R; Cella D; Leonardi C; Papp K; Gottlieb AB; Dunn M; Chiou CF; Patel V; Jahreis A
    Br J Dermatol; 2007 Dec; 157(6):1275-7. PubMed ID: 17916204
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
    Tyring S; Gottlieb A; Papp K; Gordon K; Leonardi C; Wang A; Lalla D; Woolley M; Jahreis A; Zitnik R; Cella D; Krishnan R
    Lancet; 2006 Jan; 367(9504):29-35. PubMed ID: 16399150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy study on etanercept in patients with plaque psoriasis.
    Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
    Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
    [No Abstract]   [Full Text] [Related]  

  • 5. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
    Gisondi P; Del Giglio M; Cotena C; Girolomoni G
    Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study).
    Cassano N; Loconsole F; Galluccio A; Miracapillo A; Pezza M; Vena GA
    Int J Immunopathol Pharmacol; 2006; 19(1):225-9. PubMed ID: 16569361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept in the treatment of palmoplantar pustulosis.
    Bissonnette R; Poulin Y; Bolduc C; Maari C; Provost N; Syrotuik J; Poulin-Costello CM; Nigen S
    J Drugs Dermatol; 2008 Oct; 7(10):940-6. PubMed ID: 19112757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
    Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
    Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial.
    Thaçi D; Galimberti R; Amaya-Guerra M; Rosenbach T; Robertson D; Pedersen R; Yang S; Kuligowski M; Boggs R
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):900-6. PubMed ID: 23848989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experience with etanercept in the treatment of psoriasis].
    Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
    Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
    Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
    Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of etanercept on quality of life, fatigue, and depression in psoriasis.
    Bos JD; de Korte J
    Lancet; 2006 Jan; 367(9504):6-7. PubMed ID: 16399133
    [No Abstract]   [Full Text] [Related]  

  • 15. The medical uses and side effects of etanercept with a focus on cutaneous disease.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(6):653-9. PubMed ID: 15624748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study.
    Lestre S; Diamantino F; Veloso L; Fidalgo A; Ferreira A
    Eur J Dermatol; 2011; 21(6):916-20. PubMed ID: 21983007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
    Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Stramazzotti D; Morichetti D; Bernardini ML; Mannello B; Fabris G; Offidani A
    Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-alpha inhibition.
    Wachter T; Murach WM; Bröcker EB; Schön MP
    Br J Dermatol; 2007 Sep; 157(3):627-9. PubMed ID: 17596151
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of etanercept in the management of chronic plaque psoriasis.
    Lloyd A; Reeves P; Conway P; Reynolds A; Baxter G
    Br J Dermatol; 2009 Feb; 160(2):380-6. PubMed ID: 18808413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.